- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 24, 2025 | 234.09M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $7.16B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $6.1B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $106M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $173.26M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $11.52B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $9.36B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $11.07B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $9.29B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $21.83B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $19.64B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 229.47M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $134.05M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $988.87M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.56 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.56 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $981.56M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$54.48M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$41.39M |
| Revenue | Q1 2025 · Mar 31, 2024 | $3.8B |